Bad Blood
“Will Damron is the perfect choice as narrator. His precisely articulated style makes the entire effort sound as if it is a cloak-and-dagger spy novel.”
AudioFile
New York Times bestseller
An Amazon Best Book of the Month selection
A Kirkus Reviews Pick of 10 Excellent Summer Reads
An Esquire Magazine Pick of Best Books of 2018 (So Far)
A #1 New York Times audio bestseller
A 2018 Time Magazine Top 10 Books of the Year selection in Nonfiction
Audible.com Best of the Year in Nonfiction
An iBooks bestseller in Audiobooks
Finalist for the Los Angeles Times Book Prize for Biography
A Variety Magazine Pick of 3 Books to Read If You Were Glued to the Elizabeth Holmes Documentary
A New York Post Pick of 2018's Best Books
A Paste Magazine Pick of Best Nonfiction Books of 2018
A Time Magazine Top 10 Book of the Decade in Nonfiction
Winner of Financial Times and McKinsey Business Book of the Year Award, 2018
“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Praise